During the past decade, Klinische Forschung Hannover-Mitte GmbH conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 14 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinische Forschung Hannover-Mitte GmbH" #1 sponsor was "Pfizer" with 6 trials, followed by "Biogen" with 2 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Bavarian Nordic" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinische Forschung Hannover-Mitte GmbH" #1 collaborator was "FGK Clinical Research GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Klinische Forschung Hannover-Mitte GmbH" are "Alzheimer's Disease" (3 trials), "Cardiovascular Disease" (2 trials), "Insomnia Disorder" (2 trials), "Osteoarthritis" (2 trials) and "Respiratory Syncytial Virus Infections" (2 trials). Many other conditions were trialed in "Klinische Forschung Hannover-Mitte GmbH" in a lesser frequency.

Most popular intervention types in "Klinische Forschung Hannover-Mitte GmbH" are "Drug" (17 trials), "Biological" (6 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "bococizumab (PF-04950615)" (2 trials), "placebo" (2 trials), "Ad26.COV2.S" (1 trials) and "Aducanumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinische Forschung Hannover-Mitte GmbH" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Klinische Forschung Hannover-Mitte GmbH". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Klinische Forschung Hannover-Mitte GmbH, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Klinische Forschung Hannover-Mitte GmbH, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".